Latest news
Loading news…
OWL Metabolomics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Derio, Pais Vasco, Spain Founded 2004 11-50 employees For Profit
OWL is a biotechnology company in the field of Metabolomics with pioneering diagnostics products and unique R&D services.
OWL Metabolomics was acquired by Rubió in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- IT spend
- $359K
Company Info
- Founded
- 2004
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- Derio, Pais Vasco, Spain
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jun 14, 2023
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.2
- Trend (90d)
- -0.1
Key People at OWL Metabolomics
Products Manager
Head of Data Processing Department
Chief Financial Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to OWL Metabolomics
Loading news…
FAQs about OWL Metabolomics
People who checked this page also checked these
Browse the full Acquirezy directory.